Association of the Length of the Third Stage of Labor and Blood Loss Following Vaginal Delivery

2018 ◽  
Vol 111 (3) ◽  
pp. 178-182 ◽  
Author(s):  
Nader Z. Rabie ◽  
Songthip Ounpraseuth ◽  
Dawn Hughes ◽  
Patrick Lang ◽  
Micah Wiegel ◽  
...  
Keyword(s):  
Blood Loss ◽  
Vaginal Delivery ◽  
The Third ◽  
Third Stage Of Labor ◽  
Third Stage

scholarly journals A Comparative Study of Active Management of the Third Stage of Labor IV Methergine and IM Oxytocin

2021 ◽  
pp. 267-272
Author(s):  
K. Sharmila
Keyword(s):  
Blood Loss ◽  
The United States ◽  
Active Management ◽  
P Value ◽  
Negative Effects ◽  
The Third ◽  
Third Stage Of Labor ◽  
Group I ◽  
Third Stage ◽  
The Mean

Postpartum haemorrhage (PPH) has been more common over the last three decades, accounting for 11% of all pregnancy-related deaths in the United States. In the third stage of labour, risk classification and active management are crucial preventative techniques. To avoid negative effects, a multidisciplinary approach to PPH patient care is required. To treat uterine atony, uterotonic medicines like oxytocin are used in combination with manipulative procedures like uterine massage and balloon tamponade. The amount of blood loss, duration of the third stage, need for MRP, incidence of PPH, need for repeated oxytocics, and its side effects were measured in Group I 100 women who were administered injection oxytocin 10 IU injection methergin 0.2 mg IV within one minute of the baby's delivery. The mean blood loss at vaginal delivery in Group I was 100-150 ml and in group I P value 0.027, which was statistically significant .In  Group II was 160-200 ml with P value 0.036, which was statistically significant. The mean duration of third stag labour in Group 1 was 124.6 min and Group 2 was 144.8 min intravenous methergin is a better uterotonic when compared to intramuscular oxytocin to reduce the amount of blood loss at delivery and prevent complications like atonic PPH.

Can prepartum thromboelastometry-derived parameters and fibrinogen levels really predict postpartum hemorrhage?

2017 ◽  
Vol 45 (4) ◽  
Author(s):  
Lutz Kaufner ◽  
Anne Henkelmann ◽  
Christian von Heymann ◽  
Aarne Feldheiser ◽  
Laura Mickley ◽  
...  
Keyword(s):  
Pilot Study ◽  
Blood Loss ◽  
Postpartum Hemorrhage ◽  
Multivariate Regression ◽  
Operating Characteristic ◽  
Regression Analyses ◽  
The Third ◽  
Third Stage Of Labor ◽  
Third Stage ◽  
Maximum Clot Firmness

AbstractBackground:Decreased postpartum rotational thromboelastometric parameters of coagulation (ROTEMMethods:This prospective observational pilot study included 217 healthy pregnant women. Maximum clot firmness (FIBTEM-MCF), fibrinogen levels and standard coagulation parameters were measured upon admission to the delivery room for labor and within 1 h after vaginal delivery. Blood loss was measured with a calibrated collecting drape during the third stage of labor. PPH was defined as blood loss ≥500 mL. Predictors for bleeding were identified via receiver operating characteristic analyses and bivariate and multivariate regression analyses.Results:Women with and without PPH did not differ in median FIBTEM-MCF [23 mm (25Conclusions:ROTEM

scholarly journals Comparison between oxytocin, ergometrine and misoprostol in active management of the third stage of labour: a randomized controlled trial

2018 ◽  
Vol 7 (6) ◽  
pp. 2076
Author(s):  
Abubaker Y. H. Abdel Rahim ◽  
Mohamed A. A. Gadir E. Ounsa ◽  
Rayan G. Albarakati ◽  
Elsadig Y. Mohamed ◽  
Sawsan M. Abdalla
Keyword(s):  
Blood Loss ◽  
Intravenous Infusion ◽  
Controlled Trial ◽  
University Hospital ◽  
Active Management ◽  
Singleton Pregnancy ◽  
The Third ◽  
Third Stage Of Labor ◽  
Third Stage ◽  
Sublingual Misoprostol

Background: The aim of the present study was to compare the effectiveness of sublingual misoprostol, intravenous infusion of oxytocin, and intravenous infusion of Ergometrine in reducing blood loss during the third stage of labor.Methods: This is a no-random trial study conducted in in Ribat University Hospital, Khartoum among 150 laboring ladies with a healthy singleton pregnancy. After obtaining their written informed consent to participate in the study, they were randomly assigned to one of three possible treatment groups: 400 μg of sublingual misoprostol; 10 IU of intravenous infusion oxytocin; and 0.5 mg of intravenous infusion of Ergometrine. Blood loss was estimated by weighing the collected blood and converting the weight to milliliters.Results: The shortest mean duration of the third stage of labor was seen in patients who received misoprostol (3.89±0.37 min), followed by oxytocin (4.6±0.9 min), and Ergometrine (5.45±0.9 min). The lowest mean blood loss was seen in the patients who received 400 µg misoprostol (168.36±24.83 ml), followed by those who received 10 IU oxytocin (205.56±34.82 ml), and 0.5 mg Ergometrine (214.49±35.97 ml).Conclusions: Present study showed that 400 µg sublingual misoprostol was more effective than the conventional parenteral uterotonics in reducing the amount of the blood loss during the third stage of labor and has comparable effect to that of 10 IU intravenous oxytocin in shortening the duration of third stage of labor. It also showed that the use of misoprostol reduces the need for extra-uterotonics and blood transfusion.

Sign in / Sign up

Export Citation Format

Share Document